News
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...
A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and ...
In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain inflammation.
Innovative polatuzumab vedotin plus R-CHP therapy reshapes treatment of older adult patients with diffuse large B-cell lymphoma.
City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting ...
Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results